Description
Brukinsa is a prescription medication designed to treat specific types of blood cancers, including mantle cell lymphoma (MCL) and Waldenström’s macroglobulinemia (WM). As a Bruton’s tyrosine kinase (BTK) inhibitor, Brukinsa works to interfere with the growth and spread of cancer cells, offering targeted therapy to patients facing these conditions.